Skip to main content
. 2022 May 11;11(10):2726. doi: 10.3390/jcm11102726

Figure 4.

Figure 4

The detrimental effect of piperacillin/tazobactam or meropenem was observed in all the patients, irrespective of whether they received deceased donor kidney grafts (a) or living donor kidney grafts (b).